Alternative to Chemotherapy Approved by the FDA

This week, the Food and Drug Administration approved the first immune-based treatment for lung cancer. This treatment could replace the conventional chemotherapy for certain patients. The drug from Bristol-Myers Squibb, called Opdivo, works by freeing the body’s own immune system to attack tumors. The drug is administered by intravenous infusion every two weeks. Bristol-Myers is hoping to have clinical trial results for a specific type of lung cancer by the middle of the year. [3/6/15]